

Rationally Speaking #81 - Live! Ben Goldacre on Bad Pharma
Feb 24, 2013
In a riveting discussion, Ben Goldacre, a physician and acclaimed science writer known for his 'Bad Science' column, reveals how the pharmaceutical industry is deeply flawed. He highlights the troubling lack of transparency in clinical trials and the influence of drug companies on medical data. Goldacre passionately critiques publication bias in scientific research, exposing how negative results are often ignored. He also emphasizes the urgent need for rigorous standards in drug regulation to enhance patient safety and restore trust in medicine.
AI Snips
Chapters
Books
Transcript
Episode notes
Ribocetine Story
- Ben Goldacre prescribed riboxetine, an antidepressant, based on published data.
- Unpublished data revealed riboxetine was less effective, highlighting the dangers of missing trial data.
EMA vs. Cochrane
- The European Medicines Agency (EMA) withheld trial data from Cochrane, a non-profit research group, for three years.
- This led to a ruling against the EMA, forcing them to share some data but highlighting regulatory issues.
Industry Denial
- Stephen Whitehead, CEO of the British Pharmaceutical Industries, claimed the industry publishes all trial data.
- Goldacre argues this is false, citing evidence that half of all trials remain unpublished.